Related Experiment Video
Updated: Jul 10, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Current immunotherapeutic strategies in lung cancer
Dominik Rüttinger1, Rudolf A Hatz, Karl-Walter Jauch
1Department of Surgery, Laboratory of Clinical and Experimental Tumor Immunology, Grosshadern Medical Center, Ludwig-Maximilians-University Munich, Marchioninistrasse 15, 81377 Munich, Germany. dominik.ruettinger@med.uni-muenchen.de
Abstract:
New treatment modalities, such as immunotherapeutic strategies, may help improve the currently poor prognosis and outcome of patients suffering from lung cancer. However, thus far, lung cancer has not been considered an immune-sensitive malignancy. Now, there is increasing evidence that specific humeral and cellular anti-tumor immune responses can be evoked. This article reviews immunotherapeutic strategies that are already in clinical use or well-progressed in early clinical trials. A special focus is put on non-small cell lung cancer as the most frequent type of all lung cancers.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...